# A Retrospective Cohort Study on the Side Effects of Intrathecal Morphine Administration Combined with General Anaesthesia Versus General Anaesthesia Alone in Prostatectomy Patients

**Authors:** Timon Marvin Schnabel, Katharina Fetz, Hanaa Baagil, Kim Kutun, Claus Eisenberger, Mark Ulrich Gerbershagen

PMC · DOI: 10.3390/medicina61040732 · 2025-04-15

## TL;DR

This study compares pain management and side effects of intrathecal morphine plus general anesthesia versus general anesthesia alone in prostatectomy patients.

## Contribution

The study evaluates the reintroduction of intrathecal morphine in prostatectomy anesthesia and its impact on pain and safety.

## Key findings

- Intrathecal morphine reduced postoperative pain scores significantly.
- Patients needed fewer opioids like piritramide after surgery.
- No significant increase in serious side effects like respiratory depression was observed.

## Abstract

Background and Objectives: Prostatectomy is a common surgical procedure for prostate cancer, the most frequently diagnosed cancer in the male population. The choice of anaesthetic technique has a significant impact on postoperative pain management. The changes in recommendations between 2015 and 2021 prompted this study to evaluate the impact of intrathecal morphine administration in combination with general anaesthesia compared to general anaesthesia alone on postoperative analgesic consumption and the associated side effects. Material and Methods: A single-centre retrospective cohort study was conducted, analysing data from 202 patients who underwent a prostatectomy between 2015 and 2021. Patients were divided into two groups: 147 patients received intrathecal morphine combined with general anaesthesia, while 49 patients received general anaesthesia alone. Key postoperative parameters, including numerical rating scale (NRS) scores, analgesic consumption, and side effects (e.g., nausea, pruritus, hypotension, and respiratory depression) were evaluated. Statistical analyses were performed using Mann–Whitney U-tests and multiple regression models. Results: The group receiving intrathecal morphine showed a significant decrease in NRS pain scores at rest and during movement in the recovery room (p < 0.001). The need for postoperative analgesics, especially opioids such as piritramide, was reduced in this group. No significant increase in serious side effects such as respiratory depression was observed. Conclusions: The present study investigates the potential of intrathecal morphine combined with general anaesthesia as a promising approach to improve pain management in prostatectomy patients. By reducing pain intensity, this method shows significant clinical benefits. In addition, the absence of a significant increase in serious adverse events reinforces the safety of this approach. However, further studies are warranted to assess the long-term outcomes and explore optimal dosing strategies. The reintroduction of this anaesthetic technique has great potential to improve patient recovery and satisfaction following major surgery.

## Linked entities

- **Chemicals:** piritramide (PubChem CID 9331), morphine (PubChem CID 5288826)
- **Diseases:** prostate cancer (MONDO:0005159)

## Full-text entities

- **Diseases:** hypotension (MESH:D007022), postoperative pain (MESH:D010149), cancer (MESH:D009369), prostate cancer (MESH:D011471), pruritus (MESH:D011537), nausea (MESH:D009325), respiratory depression (MESH:D012131), pain (MESH:D010146)
- **Chemicals:** piritramide (MESH:D010892), Morphine (MESH:D009020)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12028477/full.md

---
Source: https://tomesphere.com/paper/PMC12028477